| (1) |
Lowe JC. Letter to the General Medical Council. London,
United Kingdom, April 17, 2001. http://www.drlowe.com/news/drpeatfield/jclletter.htm |
| (2) |
Mary Shomon's thyroid site: http://www.thyroid-info.com/ |
| (3) |
Lowe JC. T3-induced recovery from fibromyalgia by a
hypothyroid patient resistant to T4 and desiccated thyroid. J Myofascial
Ther 1(4): 26-31, 1995. |
| (4) |
Lowe JC. The Metabolic Treatment of Fibromyalgia.
Boulder, McDowell Publishing Co., 2000. |
| (5) |
Lowe J, Honeyman-Lowe G. Thyroid disease and fibromyalgia
syndrome. Lyon Mediterranee Medical: Medecine du Sud-Est 36(1): 15-17,
2000. |
| (6) |
Derry DM: Consequences of the TSH. Brit Med J May 29, 2000. |
| (7) |
Skinner GRB, Holmes D, Ahmad A, Davies J, Benitez J.
Clinical response to thyroxine sodium in clinically hypothyroid but biochemically
euthyroid patients. J Nutri. Environ Med 10: 115-124, 2000. |
| (8) |
Greene LW. Information on hypothyroidism at Healthology website. Go to
http://www.healthology.com/
and type "Greene" in its search engine box, then follow the links to videos
from there. |
| (9) |
Shomon M. Endocrinologists defend Synthroid in Wall
Street Journal. Sticking Our Necks Out: The Thyroid Disease News Report,
July/August, 2001, p.3. |
| (10) |
Dobin R. Letter to the editor: Synthroid has record of safety and efficacy.
Wall Street Journal, June 20, 2001. |
| (11) |
http://www.synthroid.com/ |
| (12) |
http://www.aace.com/sponmain.htm |
| (13) |
Shomon M. Synthroid files for FDA approval, will remain
on market, but with production phase-out. Sticking Our Necks Out: The
Thyroid Disease News Report, July/August, 2001, p.1-2. |
| (14) |
http://www.nacb.org/Thyroid_LMPG.htm |
| (15) |
American Thyroid Association, 1999. http://www.thyroid.org/press/pr991004.htm |
| (16) |
American Association of Clinical Endocrinologists thanks Knoll Pharmaceutical
Company for an educational grant to support the development of practice
guidelines, 1996. http://www.aace.com/clinguideindex.htm |
| (17) |
Food and Drug Administration. Letter to Knoll Pharmaceutical
Company, April 26, 2001. |
| (18) |
Shomon M. FDA refuses Synthroid's generally recognized as safe and effective
status, Abbott Labs forced to submit new drug application. Sticking Our
Necks Out: The Thyroid Disease News Report, May/June, 2001, p.4. |
| (19) |
http://www.thyroid-info.com/subscribe.htm |